These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 37506959)
1. Accelerated Atherosclerosis and Management of Cardiovascular Risk in Autoimmune Rheumatic Diseases: An Updated Review. Karakasis P; Patoulias D; Stachteas P; Lefkou E; Dimitroulas T; Fragakis N Curr Probl Cardiol; 2023 Dec; 48(12):101999. PubMed ID: 37506959 [TBL] [Abstract][Full Text] [Related]
2. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases. Manolis AS; Tzioufas AG Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768 [TBL] [Abstract][Full Text] [Related]
3. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target? Manolis AS; Tzioufas AG Curr Vasc Pharmacol; 2020; 18(5):425-430. PubMed ID: 32410564 [TBL] [Abstract][Full Text] [Related]
4. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Prasad M; Hermann J; Gabriel SE; Weyand CM; Mulvagh S; Mankad R; Oh JK; Matteson EL; Lerman A Nat Rev Cardiol; 2015 Mar; 12(3):168-76. PubMed ID: 25533796 [TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331 [TBL] [Abstract][Full Text] [Related]
6. The Cardio-Rheumatology Approach to Atherosclerotic Cardiovascular Disease. Escárcega RO; García-Carrasco M; Mendoza-Pinto C Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):311-312. PubMed ID: 32718860 [No Abstract] [Full Text] [Related]
7. The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases. Fasano S; Iacono D; Riccardi A; Ciccia F; Valentini G Rheumatology (Oxford); 2020 Dec; 59(12):3593-3602. PubMed ID: 32830272 [TBL] [Abstract][Full Text] [Related]
8. [Cardiovascular risk in rheumatic diseases]. Oreská S; Tomčík M Cas Lek Cesk; 2016; 155(6):324-332. PubMed ID: 27917637 [TBL] [Abstract][Full Text] [Related]
12. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Giacomelli R; Afeltra A; Alunno A; Baldini C; Bartoloni-Bocci E; Berardicurti O; Carubbi F; Cauli A; Cervera R; Ciccia F; Cipriani P; Conti F; De Vita S; Di Benedetto P; Doria A; Drosos AA; Favalli EG; Gandolfo S; Gatto M; Grembiale RD; Liakouli V; Lories R; Lubrano E; Lunardi C; Margiotta DPE; Massaro L; Meroni P; Minniti A; Navarini L; Pendolino M; Perosa F; Pers JO; Prete M; Priori R; Puppo F; Quartuccio L; Ruffatti A; Ruscitti P; Russo B; Sarzi-Puttini P; Shoenfeld Y; Somarakis GA; Spinelli FR; Tinazzi E; Triolo G; Ursini F; Valentini G; Valesini G; Vettori S; Vitali C; Tzioufas AG Autoimmun Rev; 2017 Sep; 16(9):911-924. PubMed ID: 28705780 [TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case-Control Study from Astana, Kazakhstan. Rutskaya-Moroshan K; Abisheva S; Abisheva A; Amangeldiyeva Z; Vinnik T; Batyrkhan T Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336418 [No Abstract] [Full Text] [Related]
14. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in pediatric-onset rheumatological diseases. Barsalou J; Bradley TJ; Silverman ED Arthritis Res Ther; 2013; 15(3):212. PubMed ID: 23731870 [TBL] [Abstract][Full Text] [Related]
16. Where the immune response meets the vessel wall. Bisoendial RJ; Stroes ES; Tak PP Neth J Med; 2009 Sep; 67(8):328-33. PubMed ID: 19767659 [TBL] [Abstract][Full Text] [Related]
17. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Gasparyan AY; Stavropoulos-Kalinoglou A; Mikhailidis DP; Toms TE; Douglas KM; Kitas GD Curr Vasc Pharmacol; 2010 Jul; 8(4):437-49. PubMed ID: 19758114 [TBL] [Abstract][Full Text] [Related]
18. Emergency situations in rheumatology with a focus on systemic autoimmune diseases. Vymetal J; Skacelova M; Smrzova A; Klicova A; Schubertova M; Horak P; Zadrazil J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):20-9. PubMed ID: 26868300 [TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Zinger H; Sherer Y; Shoenfeld Y Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025 [TBL] [Abstract][Full Text] [Related]
20. Atherosclerotic vascular disease in the autoimmune rheumatologic woman. Kurmann RD; Mankad R Clin Cardiol; 2018 Feb; 41(2):258-263. PubMed ID: 29480591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]